Baozun reported Q1 2024 revenue growth of 4.9%, beating analyst estimates. Adjusted EPS loss was $0.03. Stock price gained. Services revenue up 4.1%. Cash and equivalents at $408.1M. Baozun making progress in E-commerce and Brand Management. Stock lost 32% in past year.
Japanese automaker Toyota Motor Corporation is reportedly planning to end its substantial sponsorship deal with the International Olympic Committee after the upcoming Paris Olympics.
Vivani Medical announced proof-of-concept data for a subdermal exenatide implant designed for feline obesity and diabetes, which was published in BMC Veterinary Research.
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
PRNewswire
– Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
Globe Newswire
– Results from Preclinical Model of Hyperphosphatemia